METTL14/IGF2BP2介导的STEAP1 m6A修饰加重脓毒症诱导的急性肺损伤
该研究用LPS刺激人肺微血管内皮细胞建立体外急性肺损伤模型,并建立小鼠盲肠结扎穿孔脓毒症模型,探讨STEAP1在脓毒症相关急性肺损伤中的作用及m6A修饰机制。结果发现脓毒症相关急性肺损伤患者血中STEAP1与METTL14 mRNA表达较健康志愿者上调,LPS处理增加HPMECs中STEAP1与METTL14蛋白水平;STEAP1敲低减轻LPS诱导的HPMECs凋亡、炎症反应与铁死亡,并改善LPS对成管形成的抑制;METTL14与IGF2BP2通过m6A甲基化修饰稳定STEAP1 mRNA,METTL14沉默通过降低STEAP1表达减轻LPS诱导效应,STEAP1沉默改善小鼠盲肠结扎穿孔诱导的肺损伤。作者认为这些发现提示潜在治疗靶点。
要点
- 脓毒症相关急性肺损伤患者血中STEAP1与METTL14 mRNA表达较健康志愿者上调。
- LPS处理增加人肺微血管内皮细胞中STEAP1与METTL14蛋白水平。
- STEAP1敲低减轻LPS诱导的HPMECs凋亡、炎症反应与铁死亡,并改善LPS对成管形成的抑制。
- METTL14与IGF2BP2通过m6A甲基化修饰稳定STEAP1 mRNA;METTL14沉默通过降低STEAP1表达减轻LPS诱导效应。
- STEAP1沉默改善小鼠盲肠结扎穿孔诱导的肺损伤;作者认为STEAP1是潜在治疗靶点。
适用人群与场景
- 脓毒症相关急性肺损伤患者(仅检测血中STEAP1与METTL14 mRNA表达,与健康志愿者比较)。
- 体外模型:LPS刺激的人肺微血管内皮细胞(HPMECs)。
- 体内模型:盲肠结扎穿孔诱导的多微生物脓毒症小鼠模型。
研究设计与关键结果
- 研究类型:基础研究,包含体外细胞实验与体内小鼠模型;体外用LPS刺激HPMECs建立急性肺损伤模型,体内建立小鼠盲肠结扎穿孔多微生物脓毒症模型分析STEAP1敲低对肺损伤的影响。
- 脓毒症相关急性肺损伤患者血中STEAP1与METTL14 mRNA表达水平较健康志愿者上调。
- LPS处理增加HPMECs中STEAP1与METTL14蛋白水平;STEAP1敲低减轻LPS诱导的HPMECs凋亡、炎症反应与铁死亡促进作用,并减轻LPS对成管形成的抑制作用。
- METTL14与IGF2BP2通过m6A甲基化修饰过程稳定STEAP1 mRNA表达;METTL14沉默通过降低STEAP1表达减轻LPS诱导的HPMECs效应。
- STEAP1沉默改善小鼠盲肠结扎穿孔诱导的肺损伤。
证据类型、等级与局限
- 证据类型:基础研究(体外细胞实验与小鼠模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,这些发现提示STEAP1及相关m6A修饰通路是脓毒症相关急性肺损伤的潜在治疗靶点。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: Acute lung injury (ALI) is a severe complication of sepsis, characterized by inflammation, edema, and injury to alveolar cells, leading to high mortality rates. Septic ALI is a complex disease involving multiple factors and signaling pathways. STEAP family member 1 (STEAP1) has been reported to be upregulated in a sepsis-induced ALI model. However, the role of STEAP1 in the regulation of septic ALI is not yet fully understood. Methods: The study stimulated human pulmonary microvascular endothelial cells (HPMECs) using lipopolysaccharides (LPS) to establish an in vitro ALI model. The study used quantitative real-time polymerase chain reaction to measure mRNA expression, and western blotting assay or immunohistochemistry assay to analyze protein expression. Cell Counting Kit-8 assay was performed to assess cell viability. Flow cytometry was conducted to analyze cell apoptosis. Tube formation assay was used to analyze the tube formation rate of human umbilical vein endothelial cells. Enzyme-linked immunosorbent assays were used to measure the levels of interleukin 1beta and tumor necrosis factor alpha. The levels of Fe 2+ and reactive oxygen species were determined using colorimetric and fluorometric assays, respectively. The glutathione level was also determined using a colorimetric assay. m6A RNA immunoprecipitation assay, dual-luciferase reporter assay, and RNA immunoprecipitation assay were performed to identify the association of STEAP1 with methyltransferase 14, N6-adenosine-methyltransferase noncatalytic subunit (METTL14) and insulin like growth factor 2 mRNA binding protein 2 (IGF2BP2). The transcript half-life of STEAP1 was analyzed by actinomycin D assay. Finally, a rat model of polymicrobial sepsis was established to analyze the effects of STEAP1 knockdown on lung injury in vivo . Results: We found that the mRNA expression levels of STEAP1 and METTL14 were upregulated in the blood of ALI patients induced by sepsis compared to healthy volunteers. LPS treatment increased the protein levels of STEAP1 and METTL14 in HPMECs. STEAP1 depletion attenuated LPS-induced promoting effects on HPMECs' apoptosis, inflammatory response, and ferroptosis, as well as LPS-induced inhibitory effect on tube formation. We also found that METTL14 and IGF2BP2 stabilized STEAP1 mRNA expression through the m6A methylation modification process. Moreover, METTL14 silencing attenuated LPS-induced effects by decreasing STEAP1 expression in HPMECs, and STEAP1 silencing ameliorated cecal ligation and puncture-induced lung injury of mice. Conclusion: METTL14/IGF2BP2-mediated m6A modification of STEAP1 aggravated ALI induced by sepsis. These findings suggest potential therapeutic targets for the treatment of this disease.
参考来源
- Lai J, Yu S, Li X, et al. METTL14/IGF2BP2-MEDIATED M6A MODIFICATION OF STEAP1 AGGRAVATES ACUTE LUNG INJURY INDUCED BY SEPSIS. Shock. 2024. PMID: 39193903. doi:10.1097/SHK.0000000000002456
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。